ATE99958T1 - Monoklonale antikoerper zur behandlung nach einem kontakt mit tollwutvirus. - Google Patents
Monoklonale antikoerper zur behandlung nach einem kontakt mit tollwutvirus.Info
- Publication number
- ATE99958T1 ATE99958T1 AT90305844T AT90305844T ATE99958T1 AT E99958 T1 ATE99958 T1 AT E99958T1 AT 90305844 T AT90305844 T AT 90305844T AT 90305844 T AT90305844 T AT 90305844T AT E99958 T1 ATE99958 T1 AT E99958T1
- Authority
- AT
- Austria
- Prior art keywords
- rabies
- treatment
- monoclonal antibodies
- rabies virus
- virus
- Prior art date
Links
- 241000711798 Rabies lyssavirus Species 0.000 title abstract 2
- 206010037742 Rabies Diseases 0.000 abstract 4
- 241000700605 Viruses Species 0.000 abstract 3
- 241000283073 Equus caballus Species 0.000 abstract 1
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 102000011931 Nucleoproteins Human genes 0.000 abstract 1
- 108010061100 Nucleoproteins Proteins 0.000 abstract 1
- 230000000521 hyperimmunizing effect Effects 0.000 abstract 1
- 229940042743 immune sera Drugs 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36514389A | 1989-06-08 | 1989-06-08 | |
| EP90305844A EP0402029B1 (de) | 1989-06-08 | 1990-05-30 | Monoklonale Antikörper zur Behandlung nach einem Kontakt mit Tollwutvirus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE99958T1 true ATE99958T1 (de) | 1994-01-15 |
Family
ID=23437645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90305844T ATE99958T1 (de) | 1989-06-08 | 1990-05-30 | Monoklonale antikoerper zur behandlung nach einem kontakt mit tollwutvirus. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0402029B1 (de) |
| AT (1) | ATE99958T1 (de) |
| AU (1) | AU626684B2 (de) |
| CA (1) | CA2018508A1 (de) |
| DE (1) | DE69005908T2 (de) |
| ES (1) | ES2062364T3 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4006630A1 (de) * | 1990-03-03 | 1991-09-12 | Behringwerke Ag | Humane monoklonale antikoerper gegen tollwutviren, ihre herstellung und verwendung |
| USRE47770E1 (en) | 2002-07-18 | 2019-12-17 | Merus N.V. | Recombinant production of mixtures of antibodies |
| PT2314629E (pt) | 2002-07-18 | 2014-01-22 | Merus B V | Produção recombinante de misturas de anticorpos |
| EP2395016A3 (de) | 2003-05-30 | 2012-12-19 | Merus B.V. | Entwurf und Verwendung von gepaarten unterschiedlichen Regionen von spezifisch bindenden Molekülen |
| US20100069614A1 (en) | 2008-06-27 | 2010-03-18 | Merus B.V. | Antibody producing non-human mammals |
| JP5912211B2 (ja) | 2004-01-20 | 2016-04-27 | メルス ビー．ヴィー． | 結合タンパク質の混合物 |
| NZ580607A (en) * | 2004-05-27 | 2011-05-27 | Crucell Holland Bv | Binding molecules capable of neutralizing rabies virus and uses thereof |
| AU2011218689C1 (en) * | 2004-05-27 | 2013-05-30 | Crucell Holland B.V. | Binding molecules capable of neutralizing rabies virus and uses thereof |
| EA018030B1 (ru) | 2006-06-06 | 2013-05-30 | Круселл Холланд Б.В. | Связывающие молекулы человека, имеющие убивающую активность против стафилококков, и их применения |
| AU2007328960B2 (en) | 2006-12-05 | 2013-01-17 | Crucell Holland B.V. | Liquid anti-rabies antibody formulations |
| US8821879B2 (en) | 2009-09-04 | 2014-09-02 | Xoma Technology Ltd. | Anti-botulism antibody coformulations |
| EP2630242B1 (de) | 2010-10-19 | 2017-08-02 | The Government of the United States of America as Represented by the Secretary of the Department of Health and Human Services, | Nachweis lyssavirenspezifischer antikörper |
| DK2838917T3 (da) | 2012-04-20 | 2019-08-26 | Merus Nv | Fremgangsmåder og midler til frembringelse af heterodimere ig-lignende molekyler |
| US10450367B2 (en) | 2015-08-13 | 2019-10-22 | University Of Massachusetts | Human antibodies against rabies and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4652629A (en) * | 1985-07-03 | 1987-03-24 | The Salk Institute For Biological Studies | Synthetic peptide-based anti-rabies compositions and methods |
-
1990
- 1990-05-30 AT AT90305844T patent/ATE99958T1/de not_active IP Right Cessation
- 1990-05-30 EP EP90305844A patent/EP0402029B1/de not_active Expired - Lifetime
- 1990-05-30 DE DE90305844T patent/DE69005908T2/de not_active Expired - Fee Related
- 1990-05-30 ES ES90305844T patent/ES2062364T3/es not_active Expired - Lifetime
- 1990-06-06 AU AU56868/90A patent/AU626684B2/en not_active Ceased
- 1990-06-07 CA CA002018508A patent/CA2018508A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2018508A1 (en) | 1990-12-08 |
| ES2062364T3 (es) | 1994-12-16 |
| EP0402029A3 (de) | 1991-02-13 |
| AU5686890A (en) | 1990-12-13 |
| EP0402029B1 (de) | 1994-01-12 |
| DE69005908D1 (de) | 1994-02-24 |
| EP0402029A2 (de) | 1990-12-12 |
| AU626684B2 (en) | 1992-08-06 |
| DE69005908T2 (de) | 1994-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE99958T1 (de) | Monoklonale antikoerper zur behandlung nach einem kontakt mit tollwutvirus. | |
| DK0621898T3 (da) | Kimæriske immunogener | |
| DE3789082D1 (de) | Expression eines tumorspezifischen Antigens eines rekombinanten Virusvektors sowie dessen Anwendung zur versorgenden oder heilenden Behandlung des entsprechenden Tumors. | |
| ATE175123T1 (de) | Verbesserte immunotherapeutische methode zur verhinderung oder behandlung viraler krankheiten der atemwege | |
| ATE45961T1 (de) | Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung. | |
| DK0495008T3 (da) | Vaccinekonjugat til behandling af fuglesygdomme | |
| DE68908431D1 (de) | Methode zur verminderung der immunglobulin-e-reaktion. | |
| ATE429248T1 (de) | Verwendung cd28 spezifischer monoklonaler antikörper zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von virusinfektionen | |
| ATE70310T1 (de) | Verfahren zur herstellung von monoklonalen antikoerpern gegen hbsag. | |
| Pedersen Jr et al. | Separation, isolation, and immunological studies of the structural proteins of Venezuelan equine encephalomyelitis virus | |
| ATE96675T1 (de) | Spezifische sekretions-exkretions-antigene von toxoplasma gondii, deren expressionsprodukte, verfahren zu deren herstellung und deren diagnostische und prophylaktische anwendungen. | |
| DE69109314D1 (de) | Humaner monoklonaler Antikörper und diesen enthaltende Arzneimittelzusammensetzung zur Behandlung von Pseudomonasinfektionen. | |
| Yoneda et al. | Protection of mice from rabies by intranasal immunization with inactivated rabies virus | |
| EP0328578A4 (de) | Von mca 16-88 erkanntes antigen. | |
| DK0537168T3 (da) | Antigenet CTAA 28A32, som genkendes af MCA 28A32 | |
| ES2013665A6 (es) | Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso. | |
| DK0542895T3 (da) | Krydsreaktiv influenza A immunisering | |
| ATE39055T1 (de) | Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit. | |
| DE68918127D1 (de) | Peptidbehandlung von hartnäckigen Infektionskrankheiten. | |
| NO923749D0 (no) | Bcrf1-antagonister for behandling av epstein-barr-virusinfeksjoner | |
| DE68913932D1 (de) | Arzneimittel für die Behandlung oder die Verhütung von Infektionen mit HIV durch Immunisierung, und Verfahren zur Herstellung. | |
| Kitamura et al. | Immunological Studies of Heat‐Labile Virus Inhibitors: I. Specificity of Absorption onto Sensitive Viruses and Specific Response after Virus Infections | |
| Randall et al. | Immunization with external and/or internal structural proteins protects mice from infection with the paramyxovirus SV5 | |
| Lafon et al. | Production of human monoclonal antibodies neutralizing rabies virus: An alternative to rabies immune globulin of human blood donation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |